January 26, 2026

IDEXX Laboratories, Inc. (IDXX): Investor Outlook with 10.40% Potential Upside

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a prominent player in the healthcare sector, specifically within diagnostics and research, is capturing attention with its robust market presence and..

Doximity, Inc. (DOCS) Stock Analysis: Exploring a 56% Potential Upside with Strong Analyst Support

Doximity, Inc. (NYSE: DOCS) stands poised in the healthcare information services sector, presenting an intriguing investment opportunity, particularly for those eyeing substantial potential upside. With a..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating Growth in the Healthcare Sector

Henry Schein, Inc. (NASDAQ: HSIC) stands as a formidable player in the healthcare sector, with a significant footprint in the medical distribution industry. As of its..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Exploring a 37.58% Potential Upside in the Medical Device Sector

iRhythm Holdings, Inc. (NASDAQ: IRTC) is making waves in the healthcare sector, specifically within the medical device industry. With a market capitalization of $5.17 billion, this..

Charles River Laboratories (CRL): Investor Outlook Amidst Volatility and Strategic Alliances

Charles River Laboratories International, Inc. (NYSE: CRL) commands attention in the healthcare sector, specifically within diagnostics and research. With a market cap of $10.81 billion, this..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Exploring an 18.54% Upside Potential

Prestige Consumer Healthcare Inc. (NYSE: PBH) stands as a noteworthy player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a..

Stryker Corporation (SYK) Stock Analysis: Exploring a 20% Upside in the Medical Device Sector

Stryker Corporation (NYSE: SYK), a leading player in the healthcare sector, specifically within the medical devices industry, commands a significant market presence. With a market capitalization..

Corcept Therapeutics (CORT) Stock Analysis: 114% Potential Upside Beckons Investors

Corcept Therapeutics Incorporated (NASDAQ: CORT) is capturing the attention of the investment community with its remarkable potential upside and strategic focus on groundbreaking treatments for complex..

ICON plc (ICLR) Stock Analysis: A Strategic Look at the Healthcare Leader with a 10.54% Upside Potential

ICON plc (NASDAQ: ICLR) stands as a significant player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Dublin, Ireland, ICON specializes..

Legend Biotech Corporation (LEGN) Stock Analysis: A Biotech Powerhouse with a 248% Upside Potential

Legend Biotech Corporation (NASDAQ: LEGN) is a notable player in the biotechnology sector, specializing in the development of innovative cell therapies for multiple oncology indications. With..

DexCom, Inc. (DXCM) Stock Analysis: Healthcare Giant with a 16.93% Potential Upside

DexCom, Inc. (NASDAQ: DXCM), a leading force in the medical devices sector, is drawing significant attention from investors due to its impressive growth prospects and innovative..

argenx SE (ARGX) Stock Analysis: A Biotech Powerhouse with a 27.47% Potential Upside

argenx SE (NASDAQ: ARGX), a leader in the biotechnology sector, is captivating investor attention with its significant market presence and promising product pipeline. With a market..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Exploring a 17% Potential Upside

Bio-Rad Laboratories, Inc. (NYSE: BIO), a prominent player in the healthcare sector, has been a solid name in the medical devices industry since its founding in..

Molina Healthcare Inc (MOH) Stock Report: Analyzing the Healthcare Giant’s Growth Amidst a Potential -7.53% Downside

Molina Healthcare Inc (MOH), a prominent player in the U.S. healthcare plans sector, operates primarily within Medicaid and Medicare programs. Based in Long Beach, California, Molina..

Genmab A/S (GMAB) Stock Report: Attractive Growth Potential with 12.37% Upside for Biotechnology Investors

Genmab A/S (NASDAQ: GMAB), a prominent player in the biotechnology sector, stands out with its strong growth trajectory and robust pipeline of antibody-based products aimed at..

Guardant Health, Inc. (GH) Stock Analysis: A Promising Upside in the Precision Oncology Space

Guardant Health, Inc. (NASDAQ: GH), a trailblazer in the field of precision oncology, has been capturing investor attention with its innovative approach to cancer diagnostics and..

Viatris Inc. (VTRS) Stock Analysis: Evaluating the 3.63% Dividend Yield Amidst Mixed Financial Metrics

Viatris Inc. (NASDAQ: VTRS), a global healthcare company specializing in both branded and generic drugs, has captured investors’ attention with its notable dividend yield of 3.63%...

Lantheus Holdings, Inc. (LNTH): Analyst Consensus Reveals a Robust 24.2% Potential Upside

Lantheus Holdings, Inc. (NASDAQ: LNTH), a prominent player in the healthcare sector, stands out in the specialty and generic drug manufacturing industry. Based in Bedford, Massachusetts,..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Uncovering a 63.98% Potential Upside with Innovative Sleep Apnea Solutions

Inspire Medical Systems, Inc. (NASDAQ: INSP) has captured the attention of investors with its innovative approach to treating obstructive sleep apnea (OSA), a condition that affects..

Integer Holdings Corporation (ITGR) Stock Analysis: Evaluating Growth Potential in Healthcare Tech

Integer Holdings Corporation (NYSE: ITGR), a significant player in the medical device sector, presents an intriguing opportunity for investors eyeing the healthcare industry. With a market..

Search

Funds

January 26, 2026

Search

Funds

January 26, 2026

FTSE 100

Funds